Stem Cell Authority, Ltd.
OTC: SCAL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Carlzo Bernard Cardwell
- Headquarters
- Fairlawn, United States
- IPO year
- 2005
- Market cap
- $17.4K
- Website
- https://www.stemcellauthority.com
Loading SCAL…
Loading profile data…Frequently asked questions about SCAL
What does Stem Cell Authority, Ltd. (SCAL) do?
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly...
Where does SCAL trade?
Stem Cell Authority, Ltd. (SCAL) trades on the Other OTC.
What sector is SCAL in?
Stem Cell Authority, Ltd. (SCAL) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Stem Cell Authority, Ltd.?
Carlzo Bernard Cardwell is the chief executive officer of Stem Cell Authority, Ltd. (SCAL).
Where is Stem Cell Authority, Ltd. headquartered?
Stem Cell Authority, Ltd. is headquartered in United States.
Does SCAL pay a dividend?
Stem Cell Authority, Ltd. (SCAL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SCAL go public?
Stem Cell Authority, Ltd. (SCAL) completed its initial public offering in 2005.